Search results for "Opioids"
Coadministration of antidepressants, certain opioids linked to adverse events in nursing home patients
Older nursing home patients who received both CYP2D6-metabolized opioids and CYP2D6-inhibiting antidepressants were at higher risk for worsening pain, pain-related hospitalization, pain-related ED visits, and opioid use disorder in a recent study.
https://immattersacp.org/weekly/archives/2024/07/23/1.htm
23 Jul 2024
Low back pain patients with opioid use disorder more likely to get more opioids
One-quarter of Medicare beneficiaries seeking care for acute low back pain received opioid prescriptions, according to 2016 to 2019 data. Patients with opioid use disorder received higher opioid doses and were more likely to be coprescribed gabapentin.
https://immattersacp.org/weekly/archives/2024/06/11/4.htm
11 Jun 2024
RSV vaccine approved; several actions on opioids
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/06/rsv-vaccine-approved-several-actions-on-opioids.htm
1 Jun 2023
Intervention for opioids appeared to reduce use, with no impact on pain
A trial in the U.K. randomly assigned patients with chronic noncancer pain to receive a group-based educational intervention or usual care and measured effects on opioid use and perceived pain at 12 months.
https://immattersacp.org/weekly/archives/2023/05/30/2.htm
30 May 2023
Overdose risk may be highest in week after hospital discharge for patients on long-term opioids
During the first seven days after hospital discharge, patients prescribed long-term opioid therapy overdosed on opioids at a rate six times higher than in other time periods, a retrospective study in one health system found.
https://immattersacp.org/weekly/archives/2023/01/31/4.htm
31 Jan 2023
CDC updates guideline on prescribing opioids for pain management
The guideline covers recommendations for primary care and other clinicians managing pain in outpatient settings and after patients are discharged from hospitals, EDs, or other facilities.
https://immattersacp.org/weekly/archives/2022/11/08/1.htm
8 Nov 2022
Efforts to stop coprescribing of opioids, benzodiazepines helped, but problem ongoing
Two recent studies examined national trends in opioid and benzodiazepine prescribing, one finding that prescribing of these drugs together and separately dropped nationally, while another showing that opioid prescribing for patients with alcohol use disorder (AUD) decreased in New York.
https://immattersacp.org/weekly/archives/2022/06/07/4.htm
7 Jun 2022
FDA considers new approach to safe disposal of opioids
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/06/fda-considers-new-approach-to-safe-disposal-of-opioids.htm
1 Jun 2022
Injection drug use rare among patients taking opioids for noncancer pain, study finds
Potential for injection drug use should not be used as a reason to support involuntary tapering or discontinuation of long-term prescription opioid treatment for noncancer pain, the authors noted.
https://immattersacp.org/weekly/archives/2021/11/23/5.htm
23 Nov 2021
Naloxone coprescribing appears uncommon in patients taking long-term opioids
A retrospective cross-sectional study of U.S. retail pharmacy claims found that 2.3% of long-term opioid therapy episodes included naloxone coprescribing, despite recommendations supporting this practice.
https://immattersacp.org/weekly/archives/2021/02/23/5.htm
23 Feb 2021
High-dose opioid use dropping in the VA, but opioids frequently discontinued involuntarily, studies find
Recent studies from the Veterans Health Administration looked at voluntary and involuntary opioid reduction; high-dose, long-term opioid therapy; and quality improvement efforts for opioid use disorder treatment.
https://immattersacp.org/weekly/archives/2020/11/10/2.htm
10 Nov 2020
Warning about hand sanitizer; labeling changes for opioids
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/09/warning-about-hand-sanitizer-labeling-changes-for-opioids.htm
1 Sep 2020
Overdose deaths from synthetic opioids increase while overall opioid deaths decline
From 2017 to 2018, overdose deaths related to prescription opioids and heroin decreased by 14% and 4%, respectively, and overdose deaths involving synthetic opioids increased by 10%.
https://immattersacp.org/weekly/archives/2020/03/31/4.htm
31 Mar 2020
ACP supports new CDC guidance for prescribing naloxone with opioids
Naloxone can reverse the effects of an opioid overdose if it is quickly administered.
https://immattersacp.org/weekly/archives/2019/01/15/5.htm
15 Jan 2019
Registration open for ACP webinars on diabetes, opioids, and gender equity
Topics include “Update on Diabetes Mellitus,” “Managing Patients Not Benefiting From (or Being Harmed by) Opioids,” and “Putting Gender Equity Principles into Action.”
https://immattersacp.org/weekly/archives/2018/08/28/6.htm
28 Aug 2018
Anticonvulsant may increase mortality risk when coprescribed with opioids
An association was found between concomitant exposure to pregabalin in the preceding 120 days and significantly increased odds of opioid-related death versus exposure to opioids alone, a study found.
https://immattersacp.org/weekly/archives/2018/08/21/4.htm
21 Aug 2018
ACP offers new Practice Advisor module, webinars on use of opioids for chronic pain
The module, Opioid Risk Management, helps assess a practice's ability to successfully develop a treatment plan for chronic pain and track and monitor use of opioids if prescribed.
https://immattersacp.org/weekly/archives/2018/08/14/6.htm
14 Aug 2018
ACP launches ‘Prescribing Opioids for Chronic Pain’ interactive learning module
An interactive multimedia module provides an overview of CDC guidelines on prescribing opioids for chronic pain and allows users to review common clinical questions and receive feedback while learning.
https://immattersacp.org/weekly/archives/2018/05/08/4.htm
8 May 2018
Opioids not superior to nonopioid analgesics for back pain, hip or knee osteoarthritis
There was no significant difference between groups in pain-related function, and while pain intensity was significantly better in the nonopioid group, the result did not reach a clinically predetermined level of importance.
https://immattersacp.org/weekly/archives/2018/03/13/4.htm
13 Mar 2018
Opioids may be associated with increased risk for serious invasive pneumococcal infections
Patients with invasive pneumococcal disease had significantly greater odds than control participants of being current opioid users, and associations were strongest for long-acting opioids, high-potency opioids, and high-dose opioids.
https://immattersacp.org/weekly/archives/2018/02/13/1.htm
13 Feb 2018